GSK Hit With Thalidomide Birth Defect Suit

Law360, New York (August 9, 2012, 7:23 PM EDT) -- A group of 11 plaintiffs sued GlaxoSmithKline PLC and other pharmaceutical companies in Pennsylvania court Thursday, alleging they suffered birth defects after their mothers took the morning sickness drug thalidomide in the late 1950s and early 1960s.

Thalidomide — which was developed by German pharmaceutical company Gruenenthal GmbH, also named as a defendant — was never approved for distribution by the U.S. Food and Drug Administration, but the plaintiffs say predecessor companies of GSK and Sanofi-Aventis U.S. LLC distributed millions of doses of thalidomide to doctors...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.